Literature DB >> 22467867

Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF.

Mu-Shui Dai1, Kishore B Challagundla, Xiao-Xin Sun, Lakshmi Reddy Palam, Shelya X Zeng, Ronald C Wek, Hua Lu.   

Abstract

The ARF tumor suppressor protein activates p53 in response to oncogenic stress, whereas ribosomal protein L11 induces p53 following ribosomal stress. Both proteins bind to central, albeit non-overlapping, regions of MDM2 and suppress MDM2 activity toward p53. However, it is not known whether the two pathways are functionally connected. Here we show that ARF directly binds to L11 in vitro and in cells, which then forms a complex with MDM2 and p53. L11 collaboratively enhances ARF-induced p53 transcriptional activity and cell cycle arrest. Supporting these results, knocking down L11 reduces ARF-mediated p53 accumulation and alleviates ARF-induced cell cycle arrest. Interestingly, overexpression of ARF increases the levels of ribosome-free L11 and enhances the interaction of L11 with MDM2 and p53. These results demonstrate that ARF activates p53, at least partly by induction of ribosomal stress, which results in L11 suppression of MDM2, and suggest that the ARF-MDM2-p53 and the L11-MDM2-p53 pathways are functionally connected.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467867      PMCID: PMC3366788          DOI: 10.1074/jbc.M111.311902

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  The nucleolus and transcription of ribosomal genes.

Authors:  Ivan Raska; Karel Koberna; Jan Malínský; Helena Fidlerová; Martin Masata
Journal:  Biol Cell       Date:  2004-10       Impact factor: 4.458

2.  Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.

Authors:  D Chen; E Padiernos; F Ding; I S Lossos; C D Lopez
Journal:  Cell Death Differ       Date:  2005-04       Impact factor: 15.828

3.  p19ARF links the tumour suppressor p53 to Ras.

Authors:  I Palmero; C Pantoja; M Serrano
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

4.  p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis.

Authors:  T Soussi; K Dehouche; C Béroud
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

5.  P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.

Authors:  W Tao; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.

Authors:  Y Zhang; Y Xiong
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

7.  Nucleolar Arf sequesters Mdm2 and activates p53.

Authors:  J D Weber; L J Taylor; M F Roussel; C J Sherr; D Bar-Sagi
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

8.  Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.

Authors:  J D Weber; M L Kuo; B Bothner; E L DiGiammarino; R W Kriwacki; M F Roussel; C J Sherr
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

9.  Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.

Authors:  Qi Zhang; Hui Xiao; Sergio C Chai; Quyen Q Hoang; Hua Lu
Journal:  J Biol Chem       Date:  2011-09-08       Impact factor: 5.157

10.  Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

Authors:  R Honda; H Yasuda
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

View more
  15 in total

1.  Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.

Authors:  Renu Wadhwa; Jihoon Ryu; Hyo Min Ahn; Nishant Saxena; Anupama Chaudhary; Chae-Ok Yun; Sunil C Kaul
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

2.  Scission of the p53-MDM2 Loop by Ribosomal Proteins.

Authors:  Xiang Zhou; Jun-Ming Liao; Wen-Juan Liao; Hua Lu
Journal:  Genes Cancer       Date:  2012-03

Review 3.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

Review 4.  The Evolution of the Ribosomal Protein-MDM2-p53 Pathway.

Authors:  Chad Deisenroth; Derek A Franklin; Yanping Zhang
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

5.  Balanced production of ribosome components is required for proper G1/S transition in Saccharomyces cerevisiae.

Authors:  Fernando Gómez-Herreros; Olga Rodríguez-Galán; Macarena Morillo-Huesca; Douglas Maya; María Arista-Romero; Jesús de la Cruz; Sebastián Chávez; Mari Cruz Muñoz-Centeno
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

6.  Ribosomal protein S14 negatively regulates c-Myc activity.

Authors:  Xiang Zhou; Qian Hao; Jun-Ming Liao; Peng Liao; Hua Lu
Journal:  J Biol Chem       Date:  2013-06-17       Impact factor: 5.157

7.  The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress.

Authors:  Katherine E Sloan; Markus T Bohnsack; Nicholas J Watkins
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

8.  The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress.

Authors:  Qi Zhang; Xiang Zhou; RuiZhi Wu; Amber Mosley; Shelya X Zeng; Zhen Xing; Hua Lu
Journal:  Elife       Date:  2014-10-27       Impact factor: 8.140

Review 9.  Battle against cancer: an everlasting saga of p53.

Authors:  Qian Hao; William C Cho
Journal:  Int J Mol Sci       Date:  2014-12-01       Impact factor: 5.923

Review 10.  Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability.

Authors:  Tae-Hyung Kim; Patrick Leslie; Yanping Zhang
Journal:  Oncotarget       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.